neog - Neogen's E.Coli Test adopted by Japan Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : neog - Neogen's E.Coli Test adopted by Japan

NEOG 6.285

+5.0%

2:06 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Brian Johnson who wrote (119)	12/16/1997 9:50:00 PM
From: Kurt C. Bender	of 441

Neogen Corp. Expects To Meet Or Top 2Q Net View Of 10c/Shr LANSING, Mich. (Dow Jones)--Neogen Corp. (NEOG) expects to meet or exceed analyst earnings estimates of 10 cents a share in the second quarter. For the second quarter ended Nov. 30, 1996, Neogen reported earnings of $412,740 or 8 cents a share on $3.7 million in revenues. Neogen said it will release second quarter results Jan. 6 and The company also said it released a new test for the seafood industry that can detect dangerous levels of histamine in fish in 30 minutes. In a press release Tuesday, the company said the new test uses quick water extraction, does not require methanol extraction, can be read visually and is insensitive to salt content. Neogen develops diagnostic and safety products for the food, agriculture and pharmacology markets. "Dow Jones News Service" "Copyright(c) 1997, Dow Jones & Company, Inc."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next